Ocera
is a biopharmaceutical company that focuses on the development and commercialization of ornithine phenylacetates... Read moreOcera
is a biopharmaceutical company that focuses on the development and commercialization of ornithine phenylacetates... Read more
News
Nov 05, 2018
BioPortfolio
Ocera: Ocera Therapeutics Inc Mergers Acquisitions MA Partnerships Alliances and Investment Report Report Updated 28072018 Prices from USD $350
Dec 12, 2017
The Business Journals
Ocera: Mallinckrodt wraps up $42 million deal
Dec 11, 2017
StreetInsider
Ocera: Mallinckrodt (MNK) Completes Acquisition of Ocera Therapeutics (OCRX)
Dec 08, 2017
4-traders
Ocera: Rigrodsky & Long, P.A. Files Class Action Suit Against Ocera Therapeutics, Inc.
Nov 07, 2017
Zolmax News
Ocera: Ocera Therapeutics (TZYM) & Its Competitors Critical Survey
Nov 06, 2017
Business Wire
Press Release: Ocera : Hyperammonemia - Global Clinical Trials Review, H2, 2017 - Research and Markets
Nov 02, 2017
Benzinga
Ocera: Mallinkcrodt Is Betting On Ocera Despite Doubts Around Its Liver Disease Drug
Nov 02, 2017
BioSpace
Ocera: Mallinckrodt Pays $117M for This Bay Area Biotech and Its Failed Liver Drug
Nov 02, 2017
St Louis Post Dispatch
Ocera: Mallinckrodt to buy California drug company
Oct 31, 2017
Business Wire
Press Release: Ocera : Diabetic Gastroparesis - Global Clinical Trials Review, H2, 2017 - Research and Markets
